Form 4 for CLNN Clene Inc.
Accepted 2025-12-30 00:00:00 ET · period of report 2025-12-23 · accession 0001835544-25-000005 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2025-12-30 | 2025-12-23 | CLNN | Ugwumba Chidozie | 10% | E - Exp Short | $0.00 | +424.4K | 807.5K | +111% | $0 |
| DMI | 2025-12-30 | 2025-12-23+ | CLNN | Ugwumba Chidozie | 10% | S - Sale | $6.28 | -11.7K | 799.2K | -1% | -$73.3K |
| DI | 2025-12-30 | 2025-12-23 | CLNN | Ugwumba Chidozie | 10% | E - Exp Short | $4.59 | -424.4K | 0 | -100% | -$1.95M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-23 | E | A | 424,358 | $0.00 | 807,495 | I By Symbiosis II, LLC | — | — | (F1) In connection with the cashless exercise of the pre-funded warrants, the issuer withheld shares of common stock to satisfy the $0.001 per-share exercise price, resulting in the issuance of fewer shares than the number of shares underlying the warrants exercised. |
| 2 | Common | Common Stock | 2025-12-26 | S | D | 3,350 | $6.32 | 795,824 | I By Symbiosis II, LLC | — | — | |
| 3 | Common | Common Stock | 2025-12-23 | S | D | 6,831 | $6.27 | 800,664 | I By Symbiosis II, LLC | — | — | |
| 4 | Common | Common Stock | 2025-12-24 | S | D | 1,490 | $6.27 | 799,174 | I By Symbiosis II, LLC | — | — | |
| 5 | Derivative | Pre-Funded Warrant to Purchase Common Stock | 2025-12-23 | E | D | 424,358 | $4.59 | 0 | I By Symbiosis II, LLC | $0.00 · 2024-10-01 to — | 424,358 Common Stock | (F2) The pre-funded warrants are indefinite with no specified termination date. |